The St. Baldrick's Foundation is a volunteer and donor powered charity committed to supporting
the most promising research to find cures for childhood cancers and give survivors long and
healthy lives. The foundation is dedicated to filling the funding gap between adult cancer research and pediatric cancer research. The 2021-22 priorities are as follows:
- New discovery research
- Translational research and early phase clinical trials
- Phase III clinical trials & infrastructure support of participating institutions (primarily the fall grant cycle)
- Education of new pediatric oncology researchers
In addition to research to understand the biology of childhood cancers and discover leads to more
effective treatments, topics of interest include, but are not limited to:
- Adolescents & young adults
- Survivorship, outcomes, and quality of life
- Supportive care
- Epidemiology and pediatric cancer predispositions
- Precision medicine
- Alternative & complementary therapies
The two (2) year Scholar (Career Development) Award, with an option for three (3) additional years based on progress, is meant to help develop the independent research of highly qualified individuals still early in their careers. Recipients are called St. Baldrick’s Scholars. Up to $110,000/year, two-year minimum.
This is a limited submission, early-career award. Applicants holding or awarded K-awards or R01s at the time of the LOI are not eligible to apply. The Scholar award is intended to develop the independent
pediatric cancer research careers of highly qualified investigators, not to support well
established or senior investigators. Only one (1) submission in each category will be accepted from a single institution.
More information can be found in the Guidelines.
The Letter of Intent deadline for this grant is December 3, 2021 at 5 pm EST. As this is a limited submission opportunity, only one LOI will be allowed from the institution. UTMB limited submission guidelines will apply.
Please email the following:
- one-page abstract
- timeline of planned major accomplishments
- the NIH biosketch of the applicant
in a single PDF to Melodi Moore before COB November 19. The Grants Review & Oversight Committee will review all applications and render a decision by COB November 24. This will give the chosen applicant just over a week to submit the LOI to the Foundation via Proposal Central.
We recognize that this is a quick turnaround time and may not be possible for all interested parties to apply within this timeframe, but please remember this is only the letter of intent and not the entire proposal due on December 3.